XNYSVTR
Market cap24bUSD
Dec 26, Last price
59.38USD
1D
0.19%
1Q
-6.99%
Jan 2017
-5.02%
Name
Ventas Inc
Chart & Performance
Profile
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 4,497,827 8.93% | 4,129,193 7.87% | 3,828,007 0.86% | |||||||
Cost of revenue | 3,875,983 | 2,427,792 | 2,218,255 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 621,844 | 1,701,401 | 1,609,752 | |||||||
NOPBT Margin | 13.83% | 41.20% | 42.05% | |||||||
Operating Taxes | (9,539) | (16,926) | 4,827 | |||||||
Tax Rate | 0.30% | |||||||||
NOPAT | 631,383 | 1,718,327 | 1,604,925 | |||||||
Net income | (40,973) 0.10% | (40,931) -183.52% | 49,008 -88.84% | |||||||
Dividends | (723,559) | (720,319) | (686,888) | |||||||
Dividend yield | 3.61% | 4.28% | 3.48% | |||||||
Proceeds from repurchase of equity | 108,455 | 7,204 | 617,342 | |||||||
BB yield | -0.54% | -0.04% | -3.13% | |||||||
Debt | ||||||||||
Debt current | 35,667 | 428,230 | 336,448 | |||||||
Long-term debt | 13,866,358 | 12,677,660 | 12,422,012 | |||||||
Deferred revenue | (228,326) | 13,671,513 | 13,491,743 | |||||||
Other long-term liabilities | 74,310 | (13,406,863) | (13,211,460) | |||||||
Net debt | 12,714,713 | 12,403,377 | 12,085,270 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 1,119,873 | 1,120,163 | 1,026,116 | |||||||
CAPEX | (259,415) | (454,069) | (432,969) | |||||||
Cash from investing activities | (184,664) | (859,218) | (724,140) | |||||||
Cash from financing activities | (543,749) | (283,928) | (558,466) | |||||||
FCF | 625,451 | 21,738,975 | (63,601) | |||||||
Balance | ||||||||||
Cash | 508,794 | 122,564 | 149,725 | |||||||
Long term investments | 678,518 | 579,949 | 523,465 | |||||||
Excess cash | 962,421 | 496,053 | 481,790 | |||||||
Stockholders' equity | (5,812,024) | (5,317,564) | (4,553,196) | |||||||
Invested Capital | 29,462,327 | 28,719,341 | 28,340,465 | |||||||
ROIC | 2.17% | 6.02% | 5.83% | |||||||
ROCE | 2.63% | 7.26% | 6.75% | |||||||
EV | ||||||||||
Common stock shares outstanding | 401,809 | 373,368 | 386,304 | |||||||
Price | 49.84 10.63% | 45.05 -11.87% | 51.12 4.24% | |||||||
Market cap | 20,026,161 19.06% | 16,820,228 -14.83% | 19,747,860 6.96% | |||||||
EV | 33,099,857 | 29,292,314 | 31,924,505 | |||||||
EBITDA | 1,787,705 | 2,912,156 | 2,824,864 | |||||||
EV/EBITDA | 18.52 | 10.06 | 11.30 | |||||||
Interest | 574,112 | 467,557 | 440,089 | |||||||
Interest/NOPBT | 92.32% | 27.48% | 27.34% |